Pacira Biosciences Inc
NASDAQ:PCRX
Income Statement
Earnings Waterfall
Pacira Biosciences Inc
Revenue
|
675m
USD
|
Cost of Revenue
|
-184.7m
USD
|
Gross Profit
|
490.3m
USD
|
Operating Expenses
|
-403m
USD
|
Operating Income
|
87.3m
USD
|
Other Expenses
|
-45.4m
USD
|
Net Income
|
42m
USD
|
Income Statement
Pacira Biosciences Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
86
N/A
|
111
+29%
|
141
+27%
|
170
+20%
|
198
+17%
|
219
+11%
|
231
+5%
|
241
+4%
|
249
+3%
|
256
+3%
|
267
+4%
|
273
+2%
|
276
+1%
|
280
+1%
|
282
+0%
|
280
0%
|
287
+2%
|
292
+2%
|
305
+5%
|
321
+5%
|
337
+5%
|
354
+5%
|
372
+5%
|
394
+6%
|
421
+7%
|
435
+3%
|
408
-6%
|
421
+3%
|
430
+2%
|
443
+3%
|
503
+14%
|
513
+2%
|
542
+5%
|
581
+7%
|
614
+6%
|
654
+6%
|
667
+2%
|
669
+0%
|
669
+0%
|
666
-1%
|
675
+1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(55)
|
(62)
|
(71)
|
(77)
|
(77)
|
(77)
|
(76)
|
(71)
|
(72)
|
(75)
|
(79)
|
(106)
|
(110)
|
(115)
|
(115)
|
(90)
|
(88)
|
(86)
|
(83)
|
(84)
|
(87)
|
(91)
|
(96)
|
(99)
|
(107)
|
(109)
|
(106)
|
(114)
|
(117)
|
(119)
|
(132)
|
(137)
|
(140)
|
(145)
|
(160)
|
(176)
|
(199)
|
(212)
|
(210)
|
(199)
|
(185)
|
|
Gross Profit |
31
N/A
|
49
+59%
|
69
+41%
|
93
+33%
|
120
+30%
|
142
+18%
|
155
+9%
|
170
+9%
|
177
+4%
|
182
+2%
|
188
+4%
|
167
-11%
|
166
0%
|
166
0%
|
166
+0%
|
190
+14%
|
199
+4%
|
206
+4%
|
222
+8%
|
237
+7%
|
250
+6%
|
263
+5%
|
277
+5%
|
295
+7%
|
314
+7%
|
326
+4%
|
302
-7%
|
307
+2%
|
312
+2%
|
324
+4%
|
371
+15%
|
377
+2%
|
401
+7%
|
436
+9%
|
454
+4%
|
478
+5%
|
468
-2%
|
457
-2%
|
459
+1%
|
467
+2%
|
490
+5%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(84)
|
(93)
|
(104)
|
(115)
|
(125)
|
(135)
|
(143)
|
(152)
|
(168)
|
(178)
|
(192)
|
(197)
|
(198)
|
(210)
|
(215)
|
(221)
|
(219)
|
(219)
|
(217)
|
(223)
|
(233)
|
(237)
|
(249)
|
(263)
|
(279)
|
(280)
|
(270)
|
(267)
|
(252)
|
(265)
|
(271)
|
(264)
|
(268)
|
(302)
|
(343)
|
(375)
|
(397)
|
(399)
|
(391)
|
(399)
|
(403)
|
|
Selling, General & Administrative |
(63)
|
(72)
|
(83)
|
(96)
|
(107)
|
(115)
|
(125)
|
(133)
|
(139)
|
(146)
|
(155)
|
(156)
|
(153)
|
(157)
|
(153)
|
(157)
|
(162)
|
(164)
|
(168)
|
(172)
|
(177)
|
(182)
|
(186)
|
(192)
|
(201)
|
(198)
|
(192)
|
(195)
|
(185)
|
(197)
|
(205)
|
(201)
|
(199)
|
(215)
|
(229)
|
(242)
|
(255)
|
(261)
|
(261)
|
(268)
|
(269)
|
|
Research & Development |
(22)
|
(21)
|
(21)
|
(20)
|
(19)
|
(20)
|
(18)
|
(19)
|
(29)
|
(32)
|
(38)
|
(42)
|
(46)
|
(53)
|
(62)
|
(64)
|
(57)
|
(55)
|
(48)
|
(52)
|
(56)
|
(56)
|
(61)
|
(67)
|
(72)
|
(74)
|
(69)
|
(64)
|
(59)
|
(60)
|
(59)
|
(55)
|
(56)
|
(61)
|
(75)
|
(83)
|
(85)
|
(80)
|
(73)
|
(74)
|
(76)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(4)
|
(6)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(14)
|
(26)
|
(38)
|
(51)
|
(57)
|
(57)
|
(57)
|
(57)
|
(57)
|
|
Operating Income |
(53)
N/A
|
(44)
+17%
|
(35)
+21%
|
(23)
+34%
|
(5)
+77%
|
7
N/A
|
12
+64%
|
18
+50%
|
10
-48%
|
4
-60%
|
(4)
N/A
|
(30)
-591%
|
(32)
-5%
|
(44)
-37%
|
(49)
-11%
|
(31)
+36%
|
(20)
+36%
|
(13)
+36%
|
5
N/A
|
14
+165%
|
18
+27%
|
26
+46%
|
28
+8%
|
32
+17%
|
36
+11%
|
47
+31%
|
32
-31%
|
41
+26%
|
61
+49%
|
60
-2%
|
100
+68%
|
113
+12%
|
133
+18%
|
133
+0%
|
111
-16%
|
102
-8%
|
71
-31%
|
58
-18%
|
68
+18%
|
68
-1%
|
87
+29%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(9)
|
(12)
|
(14)
|
(16)
|
(16)
|
(16)
|
(16)
|
(16)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(19)
|
(21)
|
(23)
|
(26)
|
(27)
|
(31)
|
(34)
|
(36)
|
(38)
|
(35)
|
(32)
|
(25)
|
(17)
|
(9)
|
|
Non-Reccuring Items |
(3)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(4)
|
(8)
|
(9)
|
(9)
|
(5)
|
(1)
|
(2)
|
(2)
|
(2)
|
(5)
|
(11)
|
(25)
|
(20)
|
(18)
|
(20)
|
(22)
|
(19)
|
(18)
|
(8)
|
(43)
|
(45)
|
(27)
|
(28)
|
(11)
|
(36)
|
(37)
|
(40)
|
(17)
|
|
Total Other Income |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(5)
|
(9)
|
(5)
|
2
|
3
|
7
|
0
|
(2)
|
(3)
|
(3)
|
(1)
|
(11)
|
(11)
|
(11)
|
(11)
|
(1)
|
(0)
|
|
Pre-Tax Income |
(64)
N/A
|
(52)
+19%
|
(43)
+17%
|
(32)
+27%
|
(14)
+57%
|
(1)
+95%
|
4
N/A
|
11
+149%
|
2
-80%
|
(3)
N/A
|
(11)
-263%
|
(36)
-234%
|
(38)
-4%
|
(54)
-42%
|
(66)
-22%
|
(51)
+22%
|
(43)
+17%
|
(33)
+22%
|
(11)
+67%
|
(4)
+63%
|
(0)
+90%
|
8
N/A
|
6
-19%
|
1
-82%
|
(11)
N/A
|
0
N/A
|
(8)
N/A
|
4
N/A
|
20
+403%
|
24
+21%
|
57
+135%
|
75
+31%
|
56
-25%
|
51
-10%
|
47
-7%
|
25
-47%
|
13
-47%
|
(21)
N/A
|
(5)
+78%
|
10
N/A
|
62
+523%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
1
|
1
|
(0)
|
(0)
|
(2)
|
122
|
125
|
123
|
117
|
(14)
|
(14)
|
(13)
|
(8)
|
(4)
|
3
|
10
|
0
|
(3)
|
(20)
|
|
Income from Continuing Operations |
(64)
|
(52)
|
(43)
|
(32)
|
(14)
|
(1)
|
4
|
10
|
2
|
(3)
|
(11)
|
(37)
|
(38)
|
(54)
|
(66)
|
(51)
|
(43)
|
(33)
|
(11)
|
(4)
|
(1)
|
8
|
8
|
2
|
(11)
|
(0)
|
(10)
|
126
|
146
|
148
|
174
|
62
|
42
|
39
|
39
|
21
|
16
|
(10)
|
(5)
|
7
|
42
|
|
Net Income (Common) |
(64)
N/A
|
(52)
+18%
|
(43)
+17%
|
(32)
+27%
|
(14)
+57%
|
(1)
+93%
|
4
N/A
|
10
+149%
|
2
-81%
|
(3)
N/A
|
(11)
-242%
|
(37)
-224%
|
(38)
-4%
|
(54)
-43%
|
(66)
-22%
|
(51)
+22%
|
(43)
+17%
|
(33)
+22%
|
(11)
+67%
|
(4)
+63%
|
(1)
+88%
|
8
N/A
|
8
+1%
|
2
-72%
|
(11)
N/A
|
(0)
+99%
|
(10)
-10 000%
|
126
N/A
|
146
+15%
|
148
+2%
|
174
+18%
|
62
-65%
|
42
-32%
|
39
-8%
|
39
+2%
|
21
-47%
|
16
-24%
|
(10)
N/A
|
(5)
+57%
|
7
N/A
|
42
+491%
|
|
EPS (Diluted) |
-1.92
N/A
|
-1.56
+19%
|
-1.14
+27%
|
-0.87
+24%
|
-0.39
+55%
|
-0.01
+97%
|
0.11
N/A
|
0.24
+118%
|
0.04
-83%
|
-0.09
N/A
|
-0.3
-233%
|
-0.97
-223%
|
-1.02
-5%
|
-1.43
-40%
|
-1.63
-14%
|
-1.26
+23%
|
-1.07
+15%
|
-0.83
+22%
|
-0.28
+66%
|
-0.11
+61%
|
-0.01
+91%
|
0.17
N/A
|
0.17
N/A
|
0.04
-76%
|
-0.27
N/A
|
-0.02
+93%
|
-0.25
-1 150%
|
2.84
N/A
|
3.33
+17%
|
3.21
-4%
|
3.81
+19%
|
1.36
-64%
|
0.92
-32%
|
0.84
-9%
|
0.74
-12%
|
0.45
-39%
|
0.34
-24%
|
-0.22
N/A
|
-0.08
+64%
|
0.13
N/A
|
0.81
+523%
|